Event by Novo Nordisk Foundation Science Cluster

    Conference: Harnessing airway immunity for next-gen vaccines

    The 32st Science Cluster conference, "Harnessing airway immunity for next-gen vaccines", will feature world leaders exploring the latest advancements in airway immunity and innovative vaccine development.

    Read more
    22-26 September 2025

    Intro

    The conference will feature world leaders exploring the latest advancements in airway immunity and innovative vaccine development. This meeting will bring together experts on a unique platform to exchange knowledge and foster collaboration among researchers, clinicians, vaccine developers, and global actors working to advance respiratory health

     

    Speakers

    Marco Cavaleri European Medicines Agency
    Chris Chiu Imperial College London
    Shane Crotty La Jolla Institute for Immunology
    Christine Dahlke CEPI
    Miles Davenport UNSW Sydney
    Sarah Fortune Harvard TH Chan School of Public Health
    Marion Gruber IAVI
    Carolyn King University of Basel
    Wayne Koff Next Frontier Advisors
    Florian Krammer Icahn School of Medicine at Mount Sinai & Medical University of Vienna
    Ingrid Kromann CEPI
    Erin McCafrey National Institutes of Health
    Helen McShane University of Oxford
    Bali Palunderan Stanford University
    Erica Ollman Saphire La Jolla Institute for Immunology
    Clara Schoeder Leipzig University
    Thomas Scriba University of Cape Town
    Andrew Steer Royal Children’s Hospital Melbourne

    How to apply

    Our conferences has no application fees – registration is free.

    Please note that the Novo Nordisk Foundation Science Cluster Conferences offers exclusive opportunities to network in an intimate setting with a carefully selected, limited body of participants. Allocation of seats at this conference takes place through a selection process through which our Scientific Committee chooses the best candidates for the conference. If you get accepted for the conference, your participation (excluding travels) is covered by the Novo Nordisk Foundation. We expect all participants and speakers to actively take part in the full duration of the conference.

    The call is open.

    If you wish to attend our conference, you will need to apply and submit an abstract* in our application system: Oxford Abstracts 

    • If you have not used the system before, click REGISTER to create an account. The email you sign up with, will be the email we will send information regarding the conference to.
    • You will then receive an email with which you can login.
    • When you have logged in, you can apply to the conference under the name: Harnessing airway immunity for next-gen vaccines
    • Please fill out applicant info and abstract.

    *If you are from industry or if, for another reason, it does not make sense for you to submit an abstract, you can apply with a motivation instead. Our scientific committee will evaluate your relevance for the conference based on your motivation.

    All accepted participants will be expected to present a poster at the conference.

    When can I apply: The call is open

    Abstract submission: The application deadline is 1 June 2025

    Evaluation of incoming applications: Beginning of June

    Notifications to applicants: End of June

    SHORT TALKS: Some applicants will be invited to give a short talk during the conference based on their submitted abstract. Selected applicants will be notified beginning of July.

    Registration fee, accommodation and local costs for all approved applicants are covered by the Novo Nordisk Foundation. Only travel expenses to and from the conference venue will be at your own expense.

    For more practical details about the conferences, please click here.

     

    Scientific Committee:

    • Thor Grundtvig Theander (Chair)
    • Henrik Nyhus Kløverpris
    • Rasmus Skaarup Mortensen
    • Teresa Lambe
    • Jakob Cramer​​
    • Kara-Lee Aves

    Conference topics

    Conference topics

    Vaccines and airway immunity
    Vaccine development
    Translational immunology, Vaccines & delivery
    Clinical research and regulatory pathways
    Read more